Pankaj Singhal

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

Biomatrica, Inc. produces reagents and devices used for sample collection and analysis in diagnostics systems, nucleic acid analysis, and bio banking. Its technology is used to protect analyst in samples at the molecular and cellular level, chemically position laboratory workflows on microfluidics chips. The firm’s products include DNAstable, DNAgard, RNAstable and RNAgard. The company was founded by Judy L. Müller-Cohn and Rolf Müller in 2004 and is headquartered in San Diego, CA.

Gattaco, Inc. provides a solution for self-collected, lab quality plasma. The company is based in Murrieta, CA. The company's a-pon device allows consumers to convert fingerstick blood to liquid plasma in less than 3 minutes without specialized knowledge or equipment. The plasma obtained fits seamlessly into existing testing workflows without changing established thresholds. Pankaj Singhal has been the CEO of the company since 2022.

Gattaco, Inc. provides a solution for self-collected, lab quality plasma. The company is based in Murrieta, CA. The company's a-pon device allows consumers to convert fingerstick blood to liquid plasma in less than 3 minutes without specialized knowledge or equipment. The plasma obtained fits seamlessly into existing testing workflows without changing established thresholds. Pankaj Singhal has been the CEO of the company since 2022.